Hit by workers’ rights lawsuits in Kenya, the tech giant has moved its outsourcing to a top-secret new site – where life is ...

Gravita is scaling with the recycling boom, while Amber is rebounding through diversification. Both firms are chasing growth, ...

The state government is considering outsourcing the manufacturing of driver’s licences, with critics warning the proposal ...

A’ja Wilson, Breanna Stewart and Napheesa Collier return to court to begin the chase for a coveted WNBA championship, while ...

Nina Trentmann is the former bureau chief for The Wall Street Journal’s CFO Journal. Based in New York, Nina managed the ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $118.0, along ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

The U.S. Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) have announced actions to phase out ...

Since our prior IM Update, in separate Alerts, we covered (i) the 2025 Investment Management Conference sponsored by the Investment Company ...

Elon Musk intends to focus more on Tesla, but it's unclear if he'll be able to solve a big problem of his own making: damage to its brand.